Alert
This site has not been optimised for Internet Explorer due to Microsoft no longer providing support for the browser. Please view this site using another browser such as Google Chrome or Microsoft Edge.
Te Pū rauemi KOWHEORI-19 COVID-19 resource hub

Support for people working in health during the COVID-19 pandemic. Find information about how you can support yourselves and others, including consumers, teams and colleagues which complements and aligns with Ministry of Health resources.

Kia āta kōwhiri Choosing Wisely

The Choosing Wisely campaign seeks to reduce harm from unnecessary and low-value tests and treatment.

He pokenga pū ā-iaia

Peripheral intravenous catheter infections

The infection prevention and control team at Te Tāhū Hauora is developing a quality improvement initiative to reduce Staphylococcus aureus bacteraemia associated with a peripheral intravenous catheter (PIVC).

An image of a peripheral intravenous catheter

PIVCs are the most commonly used invasive medical device in health care. PIVCs are used for therapeutic purposes such as giving medicine, fluids and blood products.  
 
At any time, over half of all patients in Aotearoa New Zealand hospitals will have a PIVC in situ. However, these devices do pose a risk to the patient and should only remain in place if they are required for the ongoing delivery of care.  
 

 Infections associated with a PIVC can be localised in the tissue around the entry site or spread to the bloodstream. At least one in four HA-SAB events in patients in our hospitals are linked to a PIVC. 
 
A 12-month review of HA-SAB events in Aotearoa New Zealand identified that medical devices were the source for just under three-quarters (71.1 percent) of all HA-SAB events.

Read the report:  Healthcare-associated Staphylococcus aureus bacteraemia: Te Whatu Ora – Health New Zealand districts. 

PIVC quality improvement  initiative

The infection prevention and control team at Te Tāhū Hauora is working on a quality improvement initiative to reduce infections associated with a PIVC. 

In May 2023, we held four regional workshops to discuss PIVC management in Aotearoa New Zealand as part of scoping for the initiative. Fifty-five clinicians with an interest in reducing PIVC infections attended the workshops. Workshop participants shared local PIVC quality improvement initiatives and discussed factors contributing to PIVC-associated infections and ideas for improvement.  

In August 2023, Te Tāhū Hauora invited clinicians to take part in a survey on PIVC management in Aotearoa New Zealand using an interactive platform called ThoughtExchange. A total of 216 participants took part. This enabled us to reach a broader range of clinicians and those who could not attend the workshops. 

Results of the workshops and ThoughtExchange were presented at the Intravenous Nursing New Zealand conference in March 2024. The presentation can be viewed here: IVNNZ 2024 conference presentation (2.4MB, pdf)

A PIVC advisory group was established in August 2023 to provide sector leadership, advice and support to the initiative. The advisory group and Te Tāhū Hauora have developed a PIVC infection prevention bundle for adults. Te Tāhū Hauora is currently working on supporting resources for this bundle.  

Look out for updates on this webpage and in our IPC newsletter. 

For any questions, please contact the IPC team at IPC@hqsc.govt.nz

Poster:  HA-SAB Engagement using ThoughtExchange (PDF).

Poster:  HA-SAB What are we going to do about increasing rates (PDF). 

Published: 14 Apr 2022 Modified: 30 Oct 2024